Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 247 with Last Name = 'uchida' and Initial = 'i'
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094640(CHEMBL140640 | N-(4-Amino-2-propyl-quinolin-6-yl)-...)
Affinity DataKi:  1.80nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094650(CHEMBL434060 | N-(4-Amino-2-ethyl-quinolin-6-yl)-2...)
Affinity DataKi:  1.80nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094648(CHEMBL139776 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  1.80nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094651(CHEMBL342580 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  2.20nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094638(CHEMBL337128 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  2.30nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094642(CHEMBL142454 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  2.60nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094646(CHEMBL139934 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  6.5nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094636(CHEMBL140103 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  7nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094634(CHEMBL140979 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  8.20nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094644(CHEMBL140519 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  12nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094639(CHEMBL142999 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  13nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157339(4-(2-Carbamimidoyl-1,2,3,4-tetrahydro-isoquinolin-...)
Affinity DataKi:  19nMAssay Description:Inhibitory concentration against human Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094647(CHEMBL143605 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  20nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094649(CHEMBL140580 | N-(1-Amino-3-methyl-isoquinolin-7-y...)
Affinity DataKi:  37nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50068488((S)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataKi:  41nMAssay Description:Inhibitory concentration against human Coagulation factor XMore data for this Ligand-Target Pair
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094637(CHEMBL139566 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  47nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094635(CHEMBL336238 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  51nMAssay Description:Compound was evaluated for its ability to displace [3H]-nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094643(CHEMBL358306 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  80nMAssay Description:Compound was evaluated for its ability to displace [3H]-nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094641(CHEMBL422641 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  82nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094645(CHEMBL143243 | N-(4-Amino-quinolin-6-yl)-2-(4-chlo...)
Affinity DataKi:  86nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094652(CHEMBL343424 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  89nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094634(CHEMBL140979 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  103nMAssay Description:Inhibition of [3H]diprenorphine (0.33 nM) binding from human Opioid receptor mu 1 expressed in CHO-K1 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094653(CHEMBL141078 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  121nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094654(Biphenyl-2-carboxylic acid (4-amino-2-methyl-quino...)
Affinity DataKi:  369nMAssay Description:Compound was evaluated for its ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1/Trypsin-2(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50068488((S)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataKi:  620nMAssay Description:Inhibitory concentration against human TrypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094634(CHEMBL140979 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  1.06E+3nMAssay Description:Inhibition of [3H]naltrindole (0.55 nM) binding from human Opioid receptor kappa 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50094634(CHEMBL140979 | N-(4-Amino-2-methyl-quinolin-6-yl)-...)
Affinity DataKi:  8.65E+3nMAssay Description:Inhibition of [3H]naltrindole (0.55 nM) binding from human Opioid receptor delta 1 expressed in CHO-K1 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1/Trypsin-2(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157339(4-(2-Carbamimidoyl-1,2,3,4-tetrahydro-isoquinolin-...)
Affinity DataKi:  1.36E+4nMAssay Description:Inhibitory concentration against human TrypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157341(3-(2-Carbamimidoyl-isoquinolin-7-yl)-2-{4-[1-(1-im...)
Affinity DataKi:  2.30E+4nMAssay Description:Mean inhibitory concentration against plasmin; n=3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50068488((S)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataKi:  2.30E+4nMAssay Description:Inhibitory concentration against human PlasminMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157339(4-(2-Carbamimidoyl-1,2,3,4-tetrahydro-isoquinolin-...)
Affinity DataKi:  7.82E+4nMAssay Description:Inhibitory concentration against human PlasminMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157335(4-(2-Carbamimidoyl-1,2,3,4-tetrahydro-isoquinolin-...)
Affinity DataKi:  7.82E+4nMAssay Description:Mean inhibitory concentration against plasmin; n=3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50157339(4-(2-Carbamimidoyl-1,2,3,4-tetrahydro-isoquinolin-...)
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory concentration against human Coagulation factor II (thrombin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50068488((S)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory concentration against human Coagulation factor II (thrombin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetRenin(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50289727(4-Hydroxy-piperidine-1-carboxylic acid ((S)-1-{[(S...)
Affinity DataIC50:  0.680nMAssay Description:In vitro renin inhibitory effect was evaluated for plasma renin activity (PRA) of human plasma, Expressed as IC50More data for this Ligand-Target Pair
In DepthDetails Article
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137956(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137948(Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137940(Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137940(Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137949(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-[1,4]di...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50409938(CHEMBL2094062)
Affinity DataIC50:  3nMAssay Description:Inhibitory concentration against human Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137953(Biphenyl-2-carboxylic acid [2-[4-(4-diethylamino-p...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137946(Biphenyl-2-carboxylic acid [2-[2-(4-dimethylamino-...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(RAT)
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137953(Biphenyl-2-carboxylic acid [2-[4-(4-diethylamino-p...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50137945(Biphenyl-2-carboxylic acid [2-[4-(4-methyl-piperaz...)
Affinity DataIC50:  5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 247 total ) | Next | Last >>
Jump to: